> One might respond along the lines of: "why are we investing in ways to operationalize a concept of 'superiority' in the first place?"
Becomes sometimes it's important. The efficacy of modern medicine is not uniform across ethnic groups. To deny this fact would effectively be to deliberately withhold treatment from some groups of people. Does that seem fair and just to you?
That's not fair, they should encourage people to include:
> Diverse research participants (e.g., understudied or underserved populations)
or in case it's due to the team they should also probably encourage:
> Diverse members of the research team (e.g., those from underrepresented sociodemographic backgrounds, from an array of career stages, from outside the United States, or with professional affiliations that are not typical at SPSP such as predominately undergraduate serving institutions, minority-serving institutions, or outside academia)
Hopefully if thay do that won't be portrayed as a bad thing by anyone.
Becomes sometimes it's important. The efficacy of modern medicine is not uniform across ethnic groups. To deny this fact would effectively be to deliberately withhold treatment from some groups of people. Does that seem fair and just to you?
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2594139/
- https://www.nature.com/scitable/topicpage/pharmacogenetics-p...